Haisheng Wang, PhD
MANAGING DIRECTOR, CHINA
Dr. Wang oversees the MyBioGate business operations in China, he focuses on investor and partner relations, and service to startup companies entry into China.
Prior to MyBioGate, Mr. Wang served as Assistant Director of Baonuo Technology Co., Ltd., Senior Researcher and Chief Operating Officer of Baekje Shenzhou, and Deputy General Manager of Yangzijiang Beijing Haiyan Pharmaceutical Co., Ltd.He founded Phenylenol Science and Technology (Beijing) Co., Ltd. and served as CEO, focusing on consulting, evaluation and internationalization in drug discovery and development. Mr. Wang is also Chairman of the China Discussion Group of the American Association of Pharmaceutical Scientists (AAPS) (2017-2018), Vice Chairman of the Generic Medicine Branch of the China Association for Pharmaceutical Quality Management, Director of the Beijing Respiratory Diseases Pharmaceutical Engineering Technology Research Center, Senior Pharmacy Engineer, and Professor at the Peking University School of Pharmacy.
Shautong Song, Ph.D.
MANAGING DIRECTOR, US
Dr. Song oversees the MyBioGate business operations in the US.
Before joining MyBioGate, Dr. Song co-founded Anhui Sinobioway Cell Therapy Inc. As a CSO, he oversees a robust research program focused on dendritic cell-base cancer vaccines and CAR-T cell therapies and supports clinical development of these products. Dr. Song also founded Icell Kealex Therapeutics in Houston, TX, USA. As a CEO, he led the IND enabling studies of a Bi-specific antibody-expressed oncolytic vaccinia virus. Dr. Song serves as adjunct Professor in Department of Hematology, The Second Affiliated Hospital of Anhui Medical University. Dr. Song is also the founding president of Chinese-American Biomedical Association (CABA) Texas Chapter. Shautong Song received his B.A in Public Health from Beijing Medical University and his Ph.D. in Immunology from Nanjing Medical University. Dr. Song was an Tenure-track assistant professor at Baylor College of Medicine at the Center for Cell and Gene Therapy, where he led a group researching adoptive CAR-T cell therapies, Dendritic cell- or Adenovirus-based cancer vaccines, and oncolytic viral therapies. Dr. Song’s research at Baylor College of Medicine was funded by NIH RO1 and DOD idea award.